Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Periprosthetic Joint Infections

Jiun-Liang Chen1, Tsung-Yu Huang2,3,4, Wei-Bin Hsu5

  • 1Department of Orthopaedic Surgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) genotypes in periprosthetic joint infection (PJI) patients vary. ST239 MRSA strains show high antibiotic resistance and biofilm formation, correlating with severe patient symptoms.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Orthopedic Surgery

Background:

  • Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty (TJA).
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a primary pathogen in PJIs, but its genotypic and phenotypic characteristics in this context are not well understood.

Purpose of the Study:

  • To investigate the genotypic and phenotypic characteristics of MRSA clones isolated from PJI patients.
  • To compare antibiotic susceptibility, biofilm formation, and patient clinical manifestations across different MRSA genogroups.

Main Methods:

  • Genome typing of 36 MRSA isolates from PJI patients collected between May 2016 and October 2019.
  • Analysis of Panton-Valentine leucocidin (PVL) prevalence, antibiotic susceptibility, and biofilm formation.
  • Investigation of patient demographics and clinical data associated with different MRSA genogroups.

Main Results:

  • Eight sequence types (STs) were identified, with ST8, ST59, and ST239 being the most prevalent.
  • ST239 MRSA isolates exhibited high resistance to ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole, and levofloxacin, alongside superior biofilm formation.
  • Patients infected with ST239 MRSA showed fever and elevated inflammatory markers (CRP, WBC); ST59 was linked to knee PJIs, with increasing trends for ST8 and other STs.

Conclusions:

  • MRSA genotypes in PJI patients display distinct genotypic and phenotypic profiles.
  • ST239 MRSA poses a significant challenge due to its resistance and virulence factors.
  • Genotypic identification of MRSA in PJIs can aid in clinical management and treatment strategies.